ENPICOM and Viroclinics-DDL receive joint MIT Zuid subsidy to accelerate and improve antibody and vaccine discovery and development Kumar Jeetendra | April 6, 2021 ‘s-Hertogenbosch (The Netherlands) – March 30, 2021 – Life Science Newswire – Viroclinics-DDL, a state-of-the-art Contract Research Organization specialized in molecular diagnostic testing and assay development, and ENPICOM, an innovative bioinformatics software engineering company, announced the approval of their joint MIT Zuid subsidy (SME Innovation Stimulation Top Sectors South Holland) application. This R&D partnership project …
Dr Rajesh Shah has been appointed Country General Manager of Azbil Telstar’s subsidiary in India Kumar Jeetendra | April 6, 2021 Terrassa (Barcelona) 2021, March 29th. Azbil Telstar announces the appointment of Dr Rajesh Shah as the Country General Manager of the subsidiary of the company in Hyderabad, India. Rajesh is going to focus his responsibility on the development of an extensive plan to address an ongoing growth demand in the region for Life Sciences service …
Even more efficient pipetting between different vessel formats Kumar Jeetendra | April 6, 2021 Four additional variants have been added to Eppendorf’s line-up of Move It® adjustable tip spacing pipettes. With adjustable cone distances, Move It® pipettes allow scientists to accelerate and simplify their workflow when pipetting between different vessel formats such as from tubes to plates. The new electronic Eppendorf Xplorer® plus Move It® models feature 8 or …
Lonza Celebrates 20th Anniversary of Nucleofector™ Cell Transfection Platform Kumar Jeetendra | April 7, 2021 Basel, Switzerland, 07 April 2021 – 2021 marks the 20th anniversary of Lonza’s groundbreaking Nucleofector™ Technology, the industry’s leading non-viral cell transfection method, which has been cited more than 10,000 times, including in research by two Nobel Laureates. The innovative Nucleofector™ Technology enables the transfer of nucleic acids and proteins directly into the cells’ nuclei …
Hester acquires technology from ICAR – IVRI for the production and commercialization of Classical Swine Fever Vaccine & Sheep Pox Vaccine Kumar Jeetendra | April 8, 2021 8 April 2021: Hester has signed two agreements with ICAR-IVRI (Indian Council of Agricultural Research – Indian Veterinary Research Institute),for acquiring technologies for the production and commercialisation of the following vaccines: 1. Classical Swine Fever Vaccine 2. Sheep Pox Vaccine These vaccines are the first that have been developed within the country by using locally …
Johnson and Johnson says in talks with Indian government for preliminary of single-portion vaccine Kumar Jeetendra | April 9, 2021 Johnson & Johnson is in talks with India’s government to start a clinical trial of its single-dose COVID-19 vaccine in the country, the company said on Friday. The U.S. drugs and health care giant’s vaccine is currently approved for use in the USA, the European Union and other countries including Thailand and South Africa. The …
Study uncovers molecular mechanisms of drug resistance in Mycobacterium tuberculosis Kumar Jeetendra | April 9, 2021 A consortium of researchers from Russia, Belarus, Japan, Germany and France led by a Skoltech scientist have uncovered the way by which Mycobacterium tuberculosis survives in iron-deficient states by using rubredoxin B, a protein by a rubredoxin family that play an essential role in adaptation to changing environmental conditions. The new study is part of …
Scientists use genetics to recognize likely drugs for early administration of COVID-19 Kumar Jeetendra | April 12, 2021 A new study using human genetics indicates researchers should prioritize clinical trials of drugs that target two proteins to manage COVID-19 in its early stages. The findings appeared online in the journal Nature Medicine at March 2021. The purpose is to identify present drugs, either FDA-approved or in clinical development for other conditions, that can …
Small SARS-CoV-2 protein may have huge ramifications for future COVID-19 medicines Kumar Jeetendra | April 12, 2021 A very small protein of SARS-CoV-2, the coronavirus that gives rise to COVID-19, may have big implications for future therapies, according to a team of Penn State researchers. Using a novel toolkit of approaches, the scientists uncovered the first full structure of the Nucleocapsid (N) protein and discovered how antibodies from COVID-19 patients interact with …
Imbalanced bacterial community in the gums connected to Alzheimer’s infection biomarker Kumar Jeetendra | April 12, 2021 Older adults with more harmful than healthy bacteria in their gums are more likely to have evidence for amyloid beta–a key biomarker for Alzheimer’s disease–in their cerebrospinal fluid (CSF), according to new research from NYU College of Dentistry and Weill Cornell Medicine. However, this imbalance in oral bacteria was not associated with another Alzheimer’s biomarker …
Expansion of Lonza’s Automated Robotic Solution for Endotoxin Testing Automates Sustainable Recombinant Factor C Assay Kumar Jeetendra | April 12, 2021 Basel, Switzerland, 12 April 2021 – Lonza has announced an expansion to its popular PyroTec® PRO Automated Robotic Solution for endotoxin testing. The new PyroWave® Reader add-on has been designed specifically for use with the sustainable PyroGene® Recombinant Factor C (rFC) Assay. This brings a third test type option to the platform, allowing QC microbiologists …
Sputnik V vaccine authorized in India Kumar Jeetendra | April 13, 2021 Moscow, April 13, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces that Drug Controller General of India (DCGI) has approved the use of the Russian Sputnik V vaccine against coronavirus in the country. India has become the 60th country to approve Sputnik V. Sputnik V is one of only three …
